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Abstract 
Objective 
Low serum cortisol concentrations have been associated with adverse prognosis in critical 
illness of diverse aetiology. We aimed to determine whether low serum cortisol 
concentrations are associated with adverse prognosis in patients with acute myocardial 
infarction.   
Design 
Nested case-control study. 
Setting 
Prospective cohort study of consecutive patients admitted with acute myocardial 
infarction to 9 Scottish hospitals.  
Patients 
100 patients who survived 30 days (controls) and 100 patients who died within 30 days 
(cases).   
Measurements and Main Results 
Admission cortisol concentrations were lower in patients who died than those who 
survived (median 1,189 versus 1,355 nmol/L, p<0.001). A cortisol concentration in the 
bottom quartile (<1,136 nmol/L) was a strong predictor of death within 30 days, and 
remained so after adjustment for age and cardiac troponin concentration (adjusted OR 
8.78, 95% CI 3.09-24.96, p<0.001).  
Conclusions 
Patients who mount a lesser cortisol stress response to acute myocardial infarction have a 
poorer early prognosis. 
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Introduction  
 
 Serum cortisol concentrations rise dramatically and rapidly in the early phase of 
acute critical illness (1). Such a response is necessary, for example to mobilize energy 
stores and protect against excessive inflammation. Higher random cortisol concentrations 
have been associated with increased case-fatality from critical illness (2;3), consistent 
with a greater stress response during more severe underlying illness. However, in some 
patients, low random cortisol is associated with increased risk of death (2); this group 
may overlap with those considered to have ‘relative adrenal insufficiency’ on the basis of 
an impaired incremental response to exogenous ACTH (3). Most studies have included 
patients with diverse underlying diseases, who may have been receiving drug treatment 
that could interfere with the hypothalamic-pituitary-adrenal axis, such as etomidate (1). In 
small case series of myocardial infarction, relatively low cortisol concentrations have 
been associated with both increased (4) and decreased (5-7) case-fatality. Relative 
adrenal insufficiency has also been postulated as contributing to morbidity and case-
fatality among patients suffering shock following cardiopulmonary arrest (8). We have 
explored the association between admission serum cortisol concentrations and 30-day 
case-fatality in a cohort of patients presenting with acute myocardial infarction.    
 
Materials and methods  
 
We previously undertook a prospective cohort study in which we recruited 2,806 
patients admitted with acute myocardial infarction to nine hospitals over ten months, 
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from June 2005 to March 2006 inclusive (9). Acute myocardial infarction was defined 
according to the Universal Definition of Myocardial Infarction (10). We used 
probabilistic record linkage methods to link our baseline data to death certificate data in 
order to determine which patients died following admission and their date of death. We 
randomly selected 100 patients who died within 30 days of admission (cases) and 100 
who were still alive at 30 days follow-up (controls). Socioeconomic status was measured 
using population quintiles of the Scottish Index of Multiple Deprivation (SIMD) index 
for the participant’s usual place of residence 
(http://www.scotland.gov.uk/Topics/Statistics/SIMD/). Residual sera from clinical 
samples taken on admission to hospital were stored at -80oC and used to measure cortisol 
concentrations by radio-immunoassay (MP Biomedicals, UK)  (intra-assay CV 5.1-7.0%, 
inter-assay CV 6.0-7.9%). Admission cortisol concentration was categorized using 
quartiles and logistic regression analysis was used to determine whether cortisol quartile 
was associated with the risk of death within 30 days. All statistical analyses were 
performed using SPSS software for Windows, version 13.0 (SPSS).  The study was 
approved by the West Glasgow Research Ethics Committee. 
 
Results  
 Among the 200 patients selected at random, sufficient residual serum was 
available for 177. Of these, 80 had died within 30 days of admission and 97 were still 
alive. Those patients who had died had significantly lower admission serum cortisol 
concentrations (median 1,189 nmol/L, IQR 957-1,373) than those who survived (median 
1,355 nmol/L, IQR 1,240-1,561) (Mann Whitney U test, p<0.001) and were significantly 
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older (Table 1). On univariate logistic regression analysis, there was a negative 
association between cortisol concentration and risk of death, with evidence of a threshold 
effect (Figure). Compared with patients whose cortisol concentration was in the top 
quartile (>1,437 nmol/L), those in the lowest quartile (<1,136 mmol/L) had a greater risk 
of death (OR 10.39, 95% CI 3.87-27.91, p<0.001) (Figure). 
 
There were no significant differences between the dead and alive groups in terms 
of sex (male 56% versus 58%, χ2 test p=0.807) or in the breakdown by SIMD quintile (χ2 
test for trend, p=0.586). Those who died were significantly older (median 77 years, IQR 
71-84) than survivors (median 68 years, IQR 54-79) (Mann Whitney U test, p<0.001), 
and increasing age was a significant predictor of risk of death (unadjusted OR for one 
year increase in age 1.07, 95% CI 1.04-1.10, p<0.001). After adjusting for age as a 
potential confounder, the lowest cortisol quartile was still significantly associated with 
increased risk of death (adjusted OR 9.37, 95% CI 3.32-26.40, p<0.001) (Figure). There 
was no significant difference between the dead and alive groups with regard to troponin 
concentration (Mann Whitney U test, p=0.132) and adjustment for troponin only slightly 
attenuated the association between cortisol and risk of death (adjusted OR 8.78, 95% CI 
3.09-24.96, p<0.001). 
 
Discussion 
 As previously reported (5), admission serum cortisol concentrations on admission 
were raised following acute myocardial infarction, by a magnitude in keeping with other 
severe acute illnesses. However, cortisol concentrations were significantly lower amongst 
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patients who subsequently died compared with those who survived. ACTH stimulation 
tests were not undertaken in this cohort, so the criteria for ‘relative adrenal insufficiency’ 
identified in previous studies of critical illness cannot be applied (3). Nonetheless, our 
results suggest that inability of the hypothalamic-pituitary-adrenal axis to mount a full 
stress response is associated with adverse outcomes not only in patients with multi-organ 
failure due to trauma or sepsis, but also in those with acute myocardial infarction.   
 
Previous studies of the association between cortisol concentration and prognosis 
following acute myocardial infarction are few and results conflicting. A previous study of 
just 34 patients also reported a negative association between cortisol concentration and 
risk of death (4). By contrast, three small studies of between 22 and 70 patients with few 
deaths suggested increased risk of death among patients with high cortisol concentrations  
(5-7). It is possible that sub-groups of patients exist in whom either very high or very low 
cortisol confers an adverse prognosis in acute myocardial infarction, as in more 
heterogeneous critical illness (2). However, in our study which comprised substantially 
larger number of deaths than any previous study, we found no evidence of increased risk 
of death among patients with high serum cortisol concentrations. 
 
In the association we demonstrated between low cortisol concentration and 
increased risk of case-fatality, we cannot exclude the possibility of residual confounding. 
We lacked data on a number of factors that vary with cortisol concentration, such as renal 
dysfunction and corticosteroid binding globulin. We were able to demonstrate that the 
association between cortisol and survival was independent of the potential confounding 
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effects of age and troponin concentration. Larger infarct size is positively associated with 
both higher cortisol concentration (5) and greater risk of death. Therefore, had we been 
able to adjust for infarct size, this could only have increased the association between low 
cortisol concentration and increased risk of death. Cortisol concentration may be causally 
related to blood pressure, glucose and lipid levels, all of which could therefore act as 
potential mediators of the association between low cortisol and risk of death. However, in 
the absence of data, we were unable to explore these possible mechanisms.    
 
Conclusions 
Low cortisol concentration on admission is an adverse prognostic indicator in 
patients with acute myocardial infarction, as it is in critically ill patients following sepsis 
or trauma. Further studies are required to corroborate our findings, adjust for potential 
residual confounders, establish the underlying mechanisms, determine the prevalence of 
relative adrenal insufficiency as defined by ACTH-stimulation testing, and establish the 
therapeutic value of glucocorticoid replacement therapy in patients with relatively 
impaired cortisol responses.  
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Table 1. Characteristics of acute coronary syndrome patients according to whether or not 
they were dead by 30 days follow-up 
 
 
  
Alive at 30 days 
 
Dead at 30 days 
 
P value* 
 N=97 
 
N=80  
      
 N % N %  
Sex      
       Male 54 56 46 58 0.807 
       Female 43 44 34 43  
Scottish deprivation quintile       
      1 10 13 9 13 0.586 
      2 10 13 7 10  
      3 15 20 11 16  
      4 16 21 16 24  
      5 24 32 24 36  
      Missing 22  13   
      
 median IQR median IQR  
      
Age (years) 68 54-79 77 71-84 <0.001 
Cortisol (nmol/L) 
 
1,355 1,240-1,561 1,189 957-1,373 <0.001 
 
N number, IQR inter-quartile range 
*χ2 for sex, χ2 for trend for deprivation quintile, Mann Whitney U for age and cortisol 
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Figure. Univariate and multivariate logistic regression analysis of the association 
between cortisol quartile and death within 30 days of myocardial infarction 
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